{"id":"https://openalex.org/W2063697432","doi":"https://doi.org/10.5414/cpp42307","title":"Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men","display_name":"Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men","alternate_titles":[],"publication_year":2004,"publication_date":"2004-06-01","ids":{"openalex":"https://openalex.org/W2063697432","doi":"https://doi.org/10.5414/cpp42307","mag":"2063697432","pmid":"https://pubmed.ncbi.nlm.nih.gov/15222722"},"language":"en","primary_location":{"id":"doi:10.5414/cpp42307","doi":"https://doi.org/10.5414/cpp42307","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp42307","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2063697432"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071412244","display_name":"Dieter L\u00fctjohann","orcid":"https://orcid.org/0000-0002-7941-8308","observed_orcids":["https://orcid.org/0000-0002-7941-8308"]},"institutions":[{"id":"https://openalex.org/I135140700","display_name":"University of Bonn","ror":"https://ror.org/041nas322","country_code":"DE","type":"education","lineage":["https://openalex.org/I135140700"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. L\u00fctjohann","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Bonn, Germany. d.luetjohann@uni-bonn.de","Department of Clinical Pharmacology, University of Bonn Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Bonn, Germany. d.luetjohann@uni-bonn.de","institution_ids":["https://openalex.org/I135140700"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Bonn Germany","institution_ids":["https://openalex.org/I135140700"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062452153","display_name":"Christian Hahn","orcid":"https://orcid.org/0000-0002-2758-7222","observed_orcids":["https://orcid.org/0000-0002-2758-7222"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Hahn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038392936","display_name":"Wilhelm Prange","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Prange","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011619563","display_name":"Thomas Sudhop","orcid":"https://orcid.org/0000-0002-6780-587X","observed_orcids":["https://orcid.org/0000-0002-6780-587X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Sudhop","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105752814","display_name":"Magnus Axelson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Axelson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111631218","display_name":"Tilman Sauerbruch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Sauerbruch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043564528","display_name":"Klaus von Bergmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. von Bergmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"C. Reichel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Reichel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.534,"has_fulltext":false,"cited_by_count":41,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.50303177,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"42","issue":"06","first_page":"307","last_page":"313"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.8227999806404114,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.09610000252723694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":1.0},{"id":"https://openalex.org/keywords/bile-acid-synthesis","display_name":"bile acid synthesis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cholesterol-synthesis","display_name":"cholesterol biosynthesis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cholesterol-absorption","display_name":"cholesterol absorption","score":0.6790000200271606},{"id":"https://openalex.org/keywords/deoxycholic-acid","display_name":"deoxycholic acid","score":0.8410000205039978},{"id":"https://openalex.org/keywords/7alpha-hydroxy-4-cholesten-3-one","display_name":"7\u03b1-hydroxy-4-cholesten-3-one","score":0.9390000104904175},{"id":"https://openalex.org/keywords/lathosterol","display_name":"lathosterol","score":0.9169999957084656},{"id":"https://openalex.org/keywords/hepatic-drug-metabolism","display_name":"hepatic drug metabolism","score":0.5830000042915344},{"id":"https://openalex.org/keywords/serum-cholesterol","display_name":"serum cholesterol","score":0.4050000011920929},{"id":"https://openalex.org/keywords/healthy-men","display_name":"healthy men","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C2780022283","wikidata":"https://www.wikidata.org/wiki/Q3218465","display_name":"Lathosterol","level":5,"score":0.9108340740203857},{"id":"https://openalex.org/C2779399885","wikidata":"https://www.wikidata.org/wiki/Q413288","display_name":"Bile acid","level":2,"score":0.7635502219200134},{"id":"https://openalex.org/C2780749602","wikidata":"https://www.wikidata.org/wiki/Q425680","display_name":"Deoxycholic acid","level":3,"score":0.7595052719116211},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.7078332901000977},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5611570477485657},{"id":"https://openalex.org/C2781089062","wikidata":"https://www.wikidata.org/wiki/Q419028","display_name":"Chenodeoxycholic acid","level":3,"score":0.5297528505325317},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4832649827003479},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.4566473364830017},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.42043182253837585},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37881407141685486},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3098298907279968},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28653061389923096},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.26752328872680664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2245481014251709},{"id":"https://openalex.org/C2778718757","wikidata":"https://www.wikidata.org/wiki/Q143623","display_name":"Sterol","level":3,"score":0.100119948387146},{"id":"https://openalex.org/C2781471481","wikidata":"https://www.wikidata.org/wiki/Q2756479","display_name":"Campesterol","level":4,"score":0.07917174696922302}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001647","descriptor_name":"Bile Acids and Salts","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D001647","descriptor_name":"Bile Acids and Salts","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013261","descriptor_name":"Sterols","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cpp42307","doi":"https://doi.org/10.5414/cpp42307","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp42307","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:15222722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15222722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2150291321","https://openalex.org/W2068982256","https://openalex.org/W2462878277","https://openalex.org/W2081147169","https://openalex.org/W2039613248","https://openalex.org/W2069676455","https://openalex.org/W1998736699","https://openalex.org/W2519537134","https://openalex.org/W2095860665","https://openalex.org/W2924314711"],"abstract_inverted_index":{"OBJECTIVE:":[0],"It":[1],"has":[2],"been":[3],"demonstrated":[4],"in":[5,29,65,115,210],"preliminary":[6],"studies":[7],"that":[8],"rifampin,":[9],"a":[10,116,134,184,204,215],"semisynthetic":[11],"antibiotic":[12],"and":[13,34,55,70,81,93,224],"known":[14],"inducer":[15],"of":[16,24,45,49,53,62,73,122,126,153,159,170,186,206,218,221],"hepatic":[17],"cytochrome":[18],"P450":[19],"3A4,":[20],"reduces":[21],"serum":[22,36,51,124,168,208,219],"concentrations":[23,48,209],"total":[25,141,171],"bile":[26,37,56,90,95,128,137,172,189,222],"acids":[27,96,173],"only":[28],"individuals":[30],"with":[31,112,148,201,214],"liver":[32],"disease":[33],"elevated":[35,150],"acid":[38,57,91,129,138,192,223],"levels.":[39],"METHODS:":[40],"We":[41],"studied":[42],"the":[43,123,127,151,187],"effect":[44],"rifampin":[46,74,113,149,202],"on":[47],"surrogate":[50],"markers":[52,220],"cholesterol":[54,63,142,160,226],"synthesis":[58],"as":[59,61],"well":[60],"absorption":[64],"10":[66],"male":[67],"subjects":[68],"before":[69],"after":[71],"administration":[72],"(600":[75],"mg/day)":[76],"for":[77,136],"6":[78],"days.":[79],"Cholesterol":[80],"its":[82],"precursors":[83],"were":[84],"analyzed":[85],"by":[86,97,105,162,176],"gas-liquid":[87],"chromatography":[88,108],"(GLC),":[89],"intermediates":[92],"individual":[94],"isotope-dilution":[98],"methods":[99],"using":[100],"GLC-mass":[101],"spectrometry":[102],"(MS)":[103],"or":[104],"high-performance":[106],"liquid":[107],"(HPLC).":[109],"RESULTS:":[110],"Treatment":[111],"resulted":[114],"70%":[117],"increase":[118,217],"(p":[119,164,178],"=":[120,165,179,195],"0.008)":[121],"concentration":[125,169],"precursor":[130],"7alpha-hydroxy-4-cholesten-3-one,":[131],"which":[132],"is":[133],"marker":[135],"production.":[139],"Serum":[140],"was":[143],"not":[144],"altered,":[145],"however,":[146],"treatment":[147,200],"ratio":[152],"lathosterol":[154],"to":[155,183],"cholesterol,":[156],"an":[157],"indicator":[158],"synthesis,":[161],"23%":[163],"0.037).":[166],"Interestingly,":[167],"decreased":[174],"slightly":[175],"29%":[177],"0.022),":[180],"mainly":[181],"due":[182],"lowering":[185],"secondary":[188],"acid,":[190],"deoxycholic":[191,207],"(-60%;":[193],"p":[194],"0.005).":[196],"CONCLUSION:":[197],"A":[198],"6-day":[199],"induces":[203],"reduction":[205],"healthy":[211],"men":[212],"associated":[213],"moderate":[216],"endogenous":[225],"synthesis.":[227]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2063697432","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
